References
- Ti L, Tobias S, Maghsoudi N, et al. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three canadian settings. Drug Alcohol Rev. 2021;40(4):580–585.
- Seely KA, Lapoint J, Moran JH, et al. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(2):234–243.
- Adams AJ, Banister SD, Irizarry L, et al. “Zombie” outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York. N Engl J Med. 2017;376(3):235–242.
- Manini AF, Krotulski AJ, Schimmel J, et al. Respiratory failure in confirmed synthetic cannabinoid overdose. Clinical Toxicology. 2022;60;(4):524–526.
- Alon MH, Saint-Fleur MO. Synthetic cannabinoid induced acute respiratory depression: case series and literature review. Respir Med Case Rep. 2017;22:137–141.
- Ontario enacts declaration of emergency to protect the public: significantly enhanced measures will help contain spread of COVID-19. Toronto: Queen’s Printer for Ontario; 2020.
- Gomis B. How the illicit drug trade is adapting to the coronavirus pandemic [Internet]. World Politics Review. 2020. Available from: https://www.worldpoliticsreview.com/articles/28696/how-the-illicit-drug-trade-is-adapting-to-the-coronavirus-pandemic
- WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. World Health Organization. 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19–-11-march-2020
- United Nations Office on Drugs and Crime (UNODC). COVID-19 and the drug supply chain: from production and trafficking to use [Internet]. UNODC. 2020. Available from: https://www.unodc.org/documents/data-and-analysis/covid/Covid-19-and-drug-supply-chain-Mai2020.pdf
- Maghsoudi N, McDonald K, Stefan C, et al. Evaluating networked drug checking services in toronto, Ontario: study protocol and rationale. Harm Reduct J. 2020;17(1):9–10.
- Ontario orders the mandatory closure of all non-essential workplaces to fight spread of COVID-19 [Internet]. Ontario Newsroom, Office of the Premier. 2020. Available from: https://news.ontario.ca/en/release/56435/ontario-orders-the-mandatory-closure-of-all-non-essential-workplaces-to-fight-spread-of-covid-19
- World Health Organization Expert Committee on Drug Dependence: forty-second report. WHO technical report series. Geneva: Word Health Organization; 2020 (License: CC BY-NC-SA 3.0 IGO. AB-FUBINACA; no. 1026).
- World Health Organization Expert Committee on Drug Dependence: forty-second report. WHO technical report series. Geneva: Word Health Organization; 2020 (License: CC BY-NC-SA 3.0 IGO. 4F-MDMB-BINACA; no. 1026).
- Jones JD, Nolan ML, Daver R, et al. Can naloxone be used to treat synthetic cannabinoid overdose? Biol Psychiatry. 2017;81(7):e51–e52.
- Richards JR, Schandera V, Elder JW. Treatment of acute cannabinoid overdose with naloxone infusion. Toxicol Commun. 2017;1;1(1):29–33.
- Ontario Drug Policy Research Network; Office of the Chief Coroner for Ontario/Ontario Forensic Pathology Service; Ontario Agency for Health Protection and Promotion (Public Health Ontario); Centre on Drug Policy Evaluation. Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic [Internet]. Toronto (ON): Ontario Drug Policy Research Network. 2020. Available from: https://www.publichealthontario.ca/-/media/documents/o/2020/opioid-mortality-covid-surveillance-report.pdf?sc_lang=en
- Toronto’s Drug Checking Service. Synthetic cannabinoid circulating in Toronto’s unregulated drug supply: ACHMINACA [Internet]. Centre on Drug Policy and Evaluation. 2020. Available from: https://drugchecking.cdpe.org/alert/achminaca/